US 9624211
Anti-cancer compounds
granted A61KA61K31/352A61K31/4184
Quick answer
US patent 9624211 (Anti-cancer compounds) held by The Board of Regents of the University of Texas System expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/352, A61K31/4184, A61K31/423, A61K31/428